Filing metadata

Accession number
0001209191-21-066497
Form type
Form 4
Filer
Oruka Therapeutics, Inc.
CIK
CIK 907654
Filed
Nov 23, 2021
Reporting period
Nov 22, 2021
Description
Insider transaction

Explore SEC Filings Hub